Top Qs
Timeline
Chat
Perspective

2C (psychedelics)

Family of phenethylamine psychedelics From Wikipedia, the free encyclopedia

2C (psychedelics)
Remove ads

2C (2C-x) is a general name for the family of psychedelic phenethylamines containing methoxy groups on the 2 and 5 positions of a benzene ring.[1][2][3] Most of these compounds also carry lipophilic substituents at the 4 position, usually resulting in more potent and more metabolically stable and longer acting compounds.[4]

Thumb
General structure of a 2C compound

Most of the currently known 2C compounds were first synthesized by Alexander Shulgin in the 1970s and 1980s and published in his book PiHKAL (Phenethylamines i Have Known And Loved).[3] Shulgin also coined the term 2C, being an acronym for the 2 carbon atoms between the benzene ring and the amino group.[5][1][3] 2C-B is the most popular of the 2C drugs.[3]

Remove ads

Use

Summarize
Perspective

The 2C drugs are orally active, are used at oral doses of 6 to 150 mg depending on the drug, and have durations of 3 to 48 hours depending on the drug.[1][6][5][7] However, many have doses in the range of 10 to 60 mg and durations in the range of 4 to 12 hours.[1] The 2C drugs produce psychedelic effects.[1][5][8][3] Some, such as 2C-B, have also been reported to have some entactogenic qualities, though findings appear to be mixed.[8][3][9][10]

More information Compound, Chemical name ...
Remove ads

Interactions

The 2C drugs are metabolized by the monoamine oxidase (MAO) enzymes, including both MAO-A and MAO-B.[1][14] As a result, they may be potentiated by monoamine oxidase inhibitors (MAOIs), such as phenelzine, tranylcypromine, moclobemide, and selegiline.[1][14][15] This may lead to overdose and serious toxicity.[1][14][15]

Remove ads

Pharmacology

Summarize
Perspective

Pharmacodynamics

Actions

The 2C drugs act as agonists of the serotonin 5-HT2 receptors, including of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors.[16][17][18][19][20] They are partial agonists of the serotonin 5-HT2A receptor.[16][17] Most of the 2C drugs have much lower affinity for the serotonin 5-HT1A receptor than for the serotonin 5-HT2A receptor.[16][17][18][19] Most of the 2C drugs have also shown about 5- to 15-fold higher affinity for the serotonin 5-HT2A receptor over the serotonin 5-HT2C receptor and about 15- to 100-fold higher affinity for the serotonin 5-HT2A receptor over the serotonin 5-HT1A receptor.[17] The psychedelic effects of the 2C drugs are thought to be mediated specifically by activation of the serotonin 5-HT2A receptor.[16][18][20]

Unlike many other phenethylamines, 2C drugs, including 2C-C, 2C-D, 2C-E, 2C-I, and 2C-T-2 among others, are inactive as monoamine releasing agents and reuptake inhibitors.[16][21][18][17][20] Most of the 2C drugs are agonists of the rat and mouse trace amine-associated receptor 1 (TAAR1).[16][22][23][17] However, most are inactive as agonists of the human TAAR1.[16][22][23][17] The 2C drugs show very weak monoamine oxidase inhibition, including of monoamine oxidase A (MAO-A) and/or monoamine oxidase B (MAO-B).[16]

More information Drug, 5-HT1A ...

Effects

In accordance with their psychedelic effects in humans, the 2C drugs produce the head-twitch response and wet dog shakes, behavioral proxies of psychedelic effects, in rodents.[16] At least some 2C drugs, such as 2C-D and 2C-E, produce hyperlocomotion at lower doses in rodents.[16] All 2C drugs produce hypolocomotion at higher doses in rodents.[16] 2C drugs, including 2C-C, 2C-D, 2C-E, and 2C-I, substitute partially to fully for psychedelics like DOM, DMT, and LSD and/or for the entactogen MDMA in rodent drug discrimination tests.[16][18] However, none of the assessed 2C drugs substituted for dextromethamphetamine, suggesting that they lack amphetamine-type or stimulant-like effects.[16][18]

In contrast to most psychedelics, at least two assessed 2C drugs, 2C-C and 2C-P, have shown reinforcing effects in rodents, including conditioned place preference (CPP) and self-administration.[16][28] The mechanism by which these effects are mediated is unknown.[16] However, it may be related to reduced expression of the dopamine transporter (DAT) and increased DAT phosphorylation, in turn resulting in increased extracellular dopamine levels in certain brain areas.[16][28] These 2C drugs might have misuse potential in humans.[16][28] Similar reinforcing effects in animals have been observed for NBOMe analogues of 2C drugs, including 25B-NBOMe, 25D-NBOMe, 25E-NBOMe, 25H-NBOMe, and 25N-NBOMe.[16][29][30][31][32][33][34]

Similarly to DOI, tolerance has been found to gradually develop to the head-twitch response induced by 2C-T-7 with chronic administration in rodents.[16]

Various 2C drugs show potent anti-inflammatory effects mediated by serotonin 5-HT2A receptor activation.[35] Among these include 2C-I, 2C-B, 2C-H, and 2C-iBu.[35][36] Others, such as 2C-B-Fly and 2C-T-33, were less effective.[35] 2C-iBu has shown a greater separation between anti-inflammatory effects and psychedelic-like effects in animals than other 2C drugs and is being investigated for possible use as a pharmaceutical drug.[36][37]

Pharmacokinetics

The 2C drugs are orally active.[1] They are metabolized by O-demethylation and deamination.[1][14] This is mediated specifically by monoamine oxidase (MAO) enzymes MAO-A and MAO-B, whereas cytochrome P450 enzymes appear to metabolize only some 2C drugs and to have only a very small role.[14]

Remove ads

History

Summarize
Perspective

2,4,5-Trimethoxyphenethylamine (2,4,5-TMPEA; 2C-O or "2C-MeO") was first synthesized by Jansen and was found to produce psychedelic effects similar to those of mescaline (3,4,5-trimethoxyphenethylamine).[38][39] He published his findings in 1931.[38][39] However, subsequent studies in the 1960s and 1970s suggested that 2,4,5-TMPEA may actually be inactive as a psychedelic in animals and humans.[38]

2C-D (2C-M) was the first of the 2C drugs besides 2C-O to be discovered.[2][40][41][42] It was synthesized and studied in animals by Ho and colleagues and they published their findings in 1970.[2][40][41][42] Alexander Shulgin synthesized 2C-B and 2C-D in 1974 and discovered their psychedelic effects in self-experiments conducted in 1974 and 1975.[1][43][2][40][44] He published his findings in the scientific literature in 1975.[1][43][2][40][44] 2C-T was first described by Shulgin and David E. Nichols in 1976.[45] 2C-I was first described by Shulgin and colleagues in 1977 and initial psychoactivity was reported by Shulgin in 1978.[38][46] Shulgin also first synthesized 2C-E in 1977.[47][48] He reviewed several of these 2C drugs in 1979.[49] Subsequently, numerous other 2C drugs have been synthesized and characterized.[5][6][2][1][43]

2C-B gained popularity as a recreational drug and MDMA alternative in the mid-1980s and became a controlled substance in the United States in 1994.[1][3] It is said to be the most popular of the 2C drugs.[3]

Remove ads

Society and culture

Canada

As of October 12, 2016, the 2C-x family of substituted phenethylamines is a controlled substance (Schedule III) in Canada.[50]

List of 2C drugs

More information Name, R3 ...
Remove ads
More information Name, Chemical name ...
Remove ads

See also

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads